Results 41 to 50 of about 1,319,500 (259)

A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin (R)) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety [PDF]

open access: yes, 2012
Aims: To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin (R)) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV).
Gerber, Stefan   +7 more
core   +1 more source

Bacterial Vaginosis: A Comprehensive Narrative on the Etiology, Clinical Features, and Management Approach

open access: yesCureus, 2022
Due to the intricate balance of the vaginal microbiota’s ecology, bacterial vaginosis is documented in one-third of females globally at various times of their lives.
Rutuja Khedkar, S. Pajai
semanticscholar   +1 more source

Clinical and laboratory criteria for diagnosis of bacterial vaginosis. Literature review

open access: yesJournal of Education, Health and Sport, 2018
The presence of bacterial vaginosis in women, especially for a long time, increases the risk of developing inflammatory diseases of the pelvic organs, creating serious problems after gynecological surgical interventions.
A. A. Gruzevskiy
doaj   +3 more sources

Perbandingan Kadar Reactive Oxygen Species (ROS) sebagai Penanda Stres Oksidatif pada Ibu Hamil Dengan dan Tanpa Vaginosis Bakterial

open access: yesObgynia, 2023
Tujuan: Menganalisis perbandingan antara kadar reactive oxygen species pada ibu hamil dengan dan tanpa vaginosis bakterial. Metode: Penelitian cross sectional dilakukan pada ibu hamil yang datang berobat ke Poliklinik RSUP Dr.
Dwicky Limbersia Aries   +5 more
doaj   +1 more source

Association between consumption of ultra-processed foods and bacterial vaginosis: a case-control study [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2022
Introduction: Bacterial vaginosis is the most common vaginal infection in women of childbearing age. Identifying nutritional risk factors as a potential therapeutic target can be important.
Morvarid Noormohammadi   +4 more
doaj   +1 more source

Bacterial vaginosis [PDF]

open access: yesClinical Microbiology Reviews, 1991
Bacterial vaginosis (BV) is the most common of the vaginitides affecting women of reproductive age. It appears to be due to an alteration in the vaginal ecology by which Lactobacillus spp., the predominant organisms in the healthy vagina, are replaced by a mixed flora including Prevotella bivia, Prevotella disiens, Porphyromonas spp., Mobiluncus spp ...
openaire   +2 more sources

Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk

open access: yesMicrobiome, 2021
HIV incidence continues to be unacceptably high in Eastern and Southern Africa, with women disproportionately affected. An increased per-contact risk of HIV acquisition among African, Caribbean, and other Black (ACB) women has been associated with the ...
E. Armstrong, R. Kaul
semanticscholar   +1 more source

Antibacterial treatment of bacterial vaginosis: current and emerging therapies [PDF]

open access: yes, 2011
Jean-Pierre MenardPôle Enfance et Famille, Conseil Général du Val-de-Marne, Créteil, FranceAbstract: Bacterial vaginosis is a common cause of malodorous vaginal discharge.
Jean-Pierre Menard, Menard JP
core   +1 more source

Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis.

open access: yesCurrent opinion in pharmacology (Print), 2021
The different Lactobacillus strains of probiotics have been applied to the treatment and prevention of bacterial vaginosis and vulvovaginal candidiasis.
Yue Han, Qing-ling Ren
semanticscholar   +1 more source

Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis. [PDF]

open access: yes, 2011
BACKGROUND: Bacterial vaginosis (BV) and Trichomonas vaginalis (TV) have been estimated to affect one-quarter to one-third of sexually active women worldwide, and are often found concurrently. Few studies have examined this relationship longitudinally to
Madhivanan, Purnima   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy